Missbrauch von Methylphenidat - ein Problem in der Schweiz?

Bruggisser, M. and Bodmer, M. and Liechti, M. E.. (2012) Missbrauch von Methylphenidat - ein Problem in der Schweiz? Praxis, 101 (5). pp. 299-305.

Full text not available from this repository.

Official URL: https://edoc.unibas.ch/84414/

Downloads: Statistics Overview


Methylphenidate (MPH) is mainly used for treatment of the attention-deficit hyperactivity syndrome (ADHS). Non-medical use of methylphenidate as recreational drug or performance enhancer has increased in recent years. Methylphenidate is also misused in combination with other drugs. Patients with ADHD are also at risk to misuse their prescribed methylphenidate medication. Oral and nasal abuse of methylphenidate is most common and is in general associated with minor or moderate sympathomimetic toxicity. In contrast, severe toxicity has been reported for both intravenous and intraarterial administration of crushed methylphenidate tablets.
Faculties and Departments:03 Faculty of Medicine > Departement Biomedizin > Department of Biomedicine, University Hospital Basel > Psychopharmacology Research (Liechti)
UniBasel Contributors:Liechti, Matthias Emanuel
Item Type:Article, refereed
Article Subtype:Research Article
Note:Publication type according to Uni Basel Research Database: Journal article
Identification Number:
Last Modified:04 Oct 2021 09:22
Deposited On:04 Oct 2021 09:22

Repository Staff Only: item control page